Abrdn Life Sciences Investors
web2abrdn Life Sciences Investors is a closed end investment fund seeking long term capital appreci...
About
abrdn Life Sciences Investors is a closed end investment fund seeking long term capital appreciation through equity investments in companies involved in healthcare and life sciences. Its portfolio includes publicly traded and privately held businesses developing or supplying biotechnology products, pharmaceuticals, diagnostic technologies, medical equipment and healthcare services. The investment mandate also encompasses selected scientific applications in agriculture and environmental management. The fund can hold restricted securities, including investments in companies that are not publicly listed. Structured as a Massachusetts business trust, it is managed by Aberdeen and its common shares trade on the New York Stock Exchange under the symbol HQL.
Explore this sector
Exchange listings
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
1 expert evaluated Abrdn Life Sciences Investors.
Experts evaluating Abrdn Life Sciences Investors
Explore the public profiles of experts who have evaluated this project.
Orbitrum Academy